Effects of E-cigarette Use on Health
Launched by UNIVERSITY OF WISCONSIN, MADISON · Sep 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the long-term health effects of using e-cigarettes, also known as electronic nicotine delivery systems (ENDS). Researchers want to understand how vaping impacts heart and lung health over time, especially looking at factors like how often someone vapes, their age, body weight, and whether they use other tobacco products. The goal is to gather important information that can help us better understand the risks associated with long-term e-cigarette use.
To participate in this study, you need to be at least 21 years old and have been using nicotine e-cigarettes regularly (at least four days a week) for over a year. You should also not have serious heart or lung issues and should not be pregnant. If you join, you'll be part of a research effort that aims to uncover how vaping affects your health. Participants will be closely monitored and can expect to contribute valuable information that may help others understand the potential risks of e-cigarettes better.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • greater than or equal to 21 years of age
- • has vaped a nicotine e-cigarette product at least 4 days/week for most weeks for greater than or equal to 12 months
- • plans to remain in catchment area for greater than or equal to 3 years
- • smoked 5 or fewer tobacco cigarettes in the past 6 months
- • no serious CV, pulmonary, or other medical problems
- • not currently pregnant
- • no plans to stop vaping
- Exclusion Criteria:
- • serious CV, pulmonary, or other medical problems (e.g., moderate or severe aortic stenosis, class III or IV heart failure, blood pressure greater than or equal to 160/100 mmHg, interstitial lung disease, sarcoidosis, Stage 3 or 4 cancer)
- • combusted or vaped cannabis use 3 days/week or more in the past 3 months
- • currently pregnant
- • not able to read an write English
- • incarceration
About University Of Wisconsin, Madison
The University of Wisconsin-Madison is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, including cutting-edge facilities and a diverse pool of expert researchers, to conduct rigorous studies that address critical health challenges. The institution's focus on translating research findings into practical applications fosters the development of new treatments and interventions, ultimately contributing to improved patient outcomes and public health initiatives. As a sponsor of clinical trials, the University of Wisconsin-Madison is dedicated to upholding the highest ethical standards and ensuring participant safety throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madison, Wisconsin, United States
Patients applied
Trial Officials
Timothy Baker, PhD
Principal Investigator
University of Wisconsin, Madison
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported